5,6-dichlorobenzimidazole

inhibits transcript elongation

Also Known As:

5,6-dichloro-1--beta-D-benzimidazole

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Neoplasms (Cancer) 10/01/2004 - "We have demonstrated that inhibition of CK2 phosphorylation events by 5,6-dichlorobenzimidazole (DRB) resulted in dramatic sensitization of tumor cells to TRAIL-induced apoptosis. "

1.	Dichlororibofuranosylbenzimidazole (DRB)